Brian Corrigan brings more than 15 years of experience in FDA regulatory strategy and policy from executive leadership roles in industry, government affairs, and consulting. Known for his ability to bridge policy/regulation and business goals, Mr. Corrigan has worked across therapeutic areas and corporate growth stages to shape regulatory approaches that expand and advance pipeline assets.
Mr. Corrigan was most recently the Senior Vice President, Regulatory & Quality Assurance and a member of the Executive Management Committee at Lexicon Pharmaceuticals, where he led the strategy and execution of all the company’s regulatory- and quality-related initiatives. For ten years prior to that, he was with Greenleaf Health (now part of ELIQUENT Life Sciences), where he designed and headed the firm’s advisory services practice supporting life science investors and companies in over 150 transactions across a broad range of biopharmaceutical sectors. Mr. Corrigan also worked with a portfolio of drug and biologics clients to address complex regulatory challenges and develop effective strategies for navigating the FDA review process.
Mr. Corrigan’s previous industry career included roles directing federal policy strategy at Vertex Pharmaceuticals, where he advised leadership on regulatory risk, agency engagement, and public policy alignment, as well as developing the U.S. federal policy and government affairs function for Astellas Pharma.
He holds a J.D. from George Mason University School of Law and a B.A. from Boston College.
